Scientists and clinicians at TRI are working towards improved diagnosis and treatment of various cancers including breast, prostate, head and neck, and skin cancers.

In 2018, an estimated 140,000 new cases of cancer were diagnosed, and just under 50,000 people died from the disease (AIHW, 2018). In Australia, the most commonly diagnosed cancers are currently breast cancer, followed by prostate cancer, colorectal cancer and melanoma.(AIHW, 2018

Researchers at TRI are working closely with clinicians to identify novel ways to detect, diagnose, monitor and treat various types of cancers. These projects include specialist cancer groups across QUT's Institute of Health and Biomedical Innovation, Mater Research, The University of Queensland.

Image: Cancer tumour spheroid with fluorescent labelling according to cell phenotype. Crystal Tonnessen (June 2015).

Key Researchers
Andrew Perkins
Nicholas Andrew Saunders
Colleen Nelson
Geoffrey Faulkner
Ingrid Winkler
Jean-Pierre Levesque
John Hooper
Judith Clements
Kristen Radford
Maher Gandhi
Show More ...
Click a program below to learn more
Blood Cancer
Breast Cancer
Cervical Cancer
Head and Neck Cancer
Kidney Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer
Skin Cancer
Interview with Prof John Hooper about pancreatic cancer research
FDA approves new saliva oral and throat cancer diagnostic test US-based biotech company Viome is commercialising an early detection liquid biopsy for oral and throat cancer, based on research by QUT...Read more
DR FERNANDO GUIMARAES AWARDED US$750K FOR BREAST CANCER RESEARCH PROJECT The University of Queensland Diamantina Institute’s TRI-based Dr Fernando Guimaraes has been awarded a US Department of...Read more
Anticancer and Antimicrobial peptide treatments Scientists based at the Translational Research Institute (TRI) are developing new, peptide-based therapies for cancers and antimicrobial treatments...Read more
Creating predictive tools for lung cancer and COVID-19 Using innovative new technologies, Dr Arutha Kulasinghe is developing an early lung cancer diagnostic, which could be used to predict lung along...Read more
World-first skin cancer treatment aims to help transplant patients A new medication which can be applied to the skin could help prevent organ transplant recipients from developing harmful skin...Read more
Drug research pivoted from prostate cancer to COVID-19 treatment Two drugs under development to treat aggressive prostate cancer will be tested to combat the deadliest response to COVID-19 infection...Read more
Genome a treasure trove for new disease treatments and diagnostics Queensland scientist Dr Mark Adams is uncovering potential new treatment targets and diagnostics for a range of diseases, including...Read more
Clinician-researcher focuses on patients with rare lymphoma Haematologist, Dr Colm Keane, has a clear focus on improving patient outcomes through his lymphoma research program at the Translational...Read more
Awakening the immune system to fight diseases Scientists at The Translational Research Institute (TRI) are harnessing the body’s front-line immune cells to fight cancer, with potential new...Read more
New autoimmune disease and cancer therapeutics edging closer to reality for patients A career dedicated to rheumatoid arthritis has led Professor Ranjeny Thomas AM to the development of a potential...Read more